Novo taps Anthropic's Claude AI for drug discovery
pharmaphorum.compharmaphorum
Novo Nordisk is leveraging Anthropic's Claude AI to advance its drug discovery processes. The collaboration applies Claude's capabilities to accelerate research and development in pharmaceutical applications.
Why it mattersThis demonstrates how generalist AI models are moving beyond software and into specialized scientific domains, potentially reducing time and cost in drug development pipelines for a major pharmaceutical company.
Read at pharmaphorum.com